You have 9 free searches left this month | for more free features.

Squamous

Showing 1 - 25 of 7,403

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 25, 2023

Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

Not yet recruiting
  • Advanced Esophageal Squamous Carcinoma With Oligometastases
  • simultaneous with radiotherapy
  • synchronous with radiotherapy
  • (no location specified)
Nov 16, 2023

Needs and Preferences of Patients With Head-neck Cutaneous SCC

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +10 more
  • Regular care with additional administration of a semi-structured interview
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Sep 13, 2023

Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • no intervention
  • Wuhan, Hubei, China
    Renmin hosptial of Wuhan University
Jul 29, 2023

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 30, 2023

Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shijiazhuang, Hebei, China
      Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
    Oct 25, 2023

    Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to

    Active, not recruiting
    • Esophageal Cancer
    • follow up
    • Guangzhou, Guangdong, China
      Jianhua Fu
    Sep 24, 2023

    Squamous Cell Cancer, Squamous Cell Carcinoma, Skin Cancer Trial in Boise (30% ascorbic acid in DMSO)

    Recruiting
    • Squamous Cell Cancer
    • +3 more
    • 30% ascorbic acid in DMSO
    • Boise, Idaho
      Center for Biomedical Research,Inc.
    Jul 2, 2023

    Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

    Not yet recruiting
    • Squamous Cell Carcinoma
      • San Francisco, California
        Power Life Sciences
      Jun 23, 2023

      Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

      Not yet recruiting
      • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
      • Guangzhou, Guangdong, China
        Sun Yat-sen University
      Oct 24, 2023

      Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx

      Not yet recruiting
      • Squamous Cell Carcinoma of the Oral Cavity
      • +3 more
      • Eliminating RT to the elective neck
      • RT standard of care
      • Erlangen, Bavaria, Germany
        Universitätsklinikum Erlangen, Strahlenklinik
      Sep 8, 2023

      Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Carrilizumab, bevacizumab,capecitabine
      • (no location specified)
      Jul 20, 2023

      Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)

      Not yet recruiting
      • Esophageal Squamous Cell Carcinoma
      • Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
      • (no location specified)
      Aug 17, 2023

      Stage T3 Squamous Cell Carcinomas of the Scalp

      Active, not recruiting
      • Squamous Cell Carcinoma
      • +2 more
        • Maastricht, Netherlands
          Ellen Oyen
        Aug 3, 2023

        Oral Cancer, Oral Squamous Cell Carcinoma Trial in Fayoum (ELISA)

        Recruiting
        • Oral Cancer
        • Oral Squamous Cell Carcinoma
        • ELISA
        • Fayoum, Egypt
          Fayoum University
        Sep 8, 2023

        Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma

        Recruiting
        • Head and Neck Squamous Cell Carcinoma
          • Hangzhou, Zhejiang, China
            Second Affiliated Hospital, School of Medicine, Zhejiang Univers
          Aug 22, 2023

          Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

          Recruiting
          • Metastatic Esophageal Squamous Cell Carcinoma
          • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors(Sintilimab)
          • Qingdao, Shandong, China
          • +1 more
          Nov 13, 2023

          Cutaneous Squamous Cell Carcinoma Trial (INCB099280)

          Not yet recruiting
          • Cutaneous Squamous Cell Carcinoma
          • (no location specified)
          May 24, 2023

          Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

          Not yet recruiting
          • Neoplasms
          • +2 more
          • Nivolumab Injection [Opdivo]
          • (no location specified)
          Jul 19, 2023

          Oral Squamous Cell Carcinoma, Oral Mucositis Trial in Guangzhou (Alfacalcidol Oral Solution, Placebo)

          Recruiting
          • Oral Squamous Cell Carcinoma
          • Oral Mucositis
          • Alfacalcidol Oral Solution
          • Placebo
          • Guangzhou, Guangdong, China
            Sun Yat-sen Memorial Hospital
          Aug 24, 2023

          Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,

          Not yet recruiting
          • Esophageal Cancer
          • +2 more
          • (no location specified)
          Aug 21, 2023

          WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA

          Recruiting
          • Oral Cancer
          • +2 more
          • Biopsy Specimens Histopathology
          • Rawalpindi, Punjab, Pakistan
            Armed Forces Institute of Pathology
          Jun 22, 2023

          Head and Neck Squamous Cell Carcinoma Trial (HS-20093)

          Not yet recruiting
          • Head and Neck Squamous Cell Carcinoma
          • (no location specified)
          Aug 17, 2023

          Resectable Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial (cadonilimab+chemo)

          Not yet recruiting
          • Resectable Esophageal Squamous Cell Carcinoma
          • Neoadjuvant Therapy
          • (no location specified)
          Apr 18, 2023

          Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

          Not yet recruiting
          • Locally Advanced Head and Neck Squamous Cell Carcinoma
          • (no location specified)
          Mar 20, 2023